Samir Rashmikant Patel - Dec 26, 2024 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role
Director
Signature
/s/ Torsten Hombeck, as Attorney-in-Fact
Stock symbol
AKTX
Transactions as of
Dec 26, 2024
Transactions value $
$1,800
Form type
4
Date filed
12/30/2024, 04:30 PM
Previous filing
Dec 27, 2024
Next filing
Jan 7, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKTX Ordinary Shares, par value $0.0001 per share Award $1.6K +3.2M +0.06% $0.00 5.25B Dec 26, 2024 PranaBio Investments LLC F1, F2
transaction AKTX Ordinary Shares, par value $0.0001 per share Award $200 +400K +0.01% $0.00 5.25B Dec 27, 2024 PranaBio Investments LLC F1, F2, F3
holding AKTX Ordinary Shares, par value $0.0001 per share 91.4M Dec 26, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
F2 On December 26, 2024, the Reporting Person acquired 3,200,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share.
F3 On December 27, 2024 the Reporting Person acquired 400,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share.